1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
These biotechnology companies are making important strides in treating many forms of cancer.
Preferred stocks typically aren’t first, second or even third to mind when investors think about what they want to include in their portfolios.
But if you’re an income hunter and you don’t...
Companies with outsize growth prospects aren't hard to find. High-growth stocks that also are high on quality are another matter.
Seemingly every other week, a so-called unicorn files...
More Investing News »